Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript February 26, 2026 Amphastar Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.73 EPS, ...
Revised guidelines require Points of Presence to compensate subscribers for service delays or operational failures without waiting for complaints. The move reinforces accountability, transparency, and ...
News-Medical.Net on MSN
Toddler thrives after receiving newly FDA-approved cochlear implant system
Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results